Back to User profile » Professor Paolo Gisondi
Papers published by Professor Paolo Gisondi:
Biosimilars for the Treatment of Moderate to Severe Chronic Plaque Psoriasis
Gisondi P, Bellinato F, Curic T, Girolomoni G
Psoriasis: Targets and Therapy 2025, 15:401-410
Published Date: 18 August 2025
Effectiveness and Safety of Tildrakizumab in Elderly and Frail Elderly Psoriatic Patients Up to 2 years
Mastorino L, Dapavo P, Burlando M, Gisondi P, Maronese CA, Ruggiero A, Galluzzo M, Pisani MC, Sacchelli L, Caldarola G, Avallone G, Marzano AV, Megna M, Campione E, Loconsole F, Bardazzi F, De Simone C, Quaglino P, Ribero S
Psoriasis: Targets and Therapy 2025, 15:339-350
Published Date: 4 August 2025
Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study
Talamonti M, Russo F, Malara G, Hansel K, Papini M, Cattaneo A, Parodi A, Chiricozzi A, Malagoli P, Bardazzi F, Brazzelli V, Dapavo P, Gisondi P, Zane C, Potenza C, Cantoresi F, Fargnoli MC, Trevisini S, Brianti P, Pescitelli L, Gigante G, Bartezaghi M, Caputo L, Aloisi E, Costanzo A
Clinical, Cosmetic and Investigational Dermatology 2023, 16:847-852
Published Date: 1 April 2023
Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis
Gisondi P, Bellinato F, Maurelli M, Geat D, Zabotti A, McGonagle D, Girolomoni G
Psoriasis: Targets and Therapy 2022, 12:213-220
Published Date: 10 August 2022
Latest Advances for the Treatment of Chronic Plaque Psoriasis with Biologics and Oral Small Molecules
Bellinato F, Gisondi P, Girolomoni G
Biologics: Targets and Therapy 2021, 15:247-253
Published Date: 29 June 2021
Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis
Gisondi P, Girolomoni G
Drug Design, Development and Therapy 2016, 10:1763-1770
Published Date: 25 May 2016